Latest & greatest articles for gestational diabetes

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on gestational diabetes or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on gestational diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for gestational diabetes

81. Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes. (Abstract)

Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes. Gestational diabetes mellitus (GDM) is associated with adverse health outcomes for both mother and infant both perinatally and long-term. Women with a history of GDM are at risk of recurrence in subsequent pregnancies and may benefit from intervention in the interconception period to improve maternal and infant health outcomes.To investigate the effects of interconception care (...) assessed study eligibility. In future updates of this review, at least two review authors will extract data and assess the risk of bias of included studies.One ongoing trial was identified. No eligible completed trials were identified.The role of interconception care for women with a history of gestational diabetes remains unclear. Randomised controlled trials are required evaluating different forms and protocols of interconception care for these women on perinatal and long-term maternal and infant

2013 Cochrane

82. Fasting Plasma Glucose at 24-28 Weeks to Screen for Gestational Diabetes Mellitus: New evidence from China Full Text available with Trip Pro

Fasting Plasma Glucose at 24-28 Weeks to Screen for Gestational Diabetes Mellitus: New evidence from China To evaluate the usefulness of a fasting plasma glucose (FPG) at 24-28 weeks' gestation to screen for gestational diabetes mellitus (GDM).The medical records and results of a 75-g 2-h oral glucose tolerance test (OGTT) of 24,854 pregnant women without known pre-GDM attending prenatal clinics in 15 hospitals in China were examined.FPG cutoff value of 5.1 mmol/L identified 3,149 (12.1 (...) %) pregnant women with GDM. FPG cutoff value of 4.4 mmol/L ruled out GDM in 15,369 (38.2%) women. With use of this cutoff point, 12.2% of patients with mild GDM will be missed. The positive predictive value is 0.322, and the negative predictive value is 0.928.FPG at 24-28 weeks' gestation could be used as a screening test to identify GDM patients in low-resource regions. Women with an FPG between ≥4.4 and ≤5.0 mmol/L would require a 75-g OGTT to diagnose GDM. This would help to avoid approximately one

2013 EvidenceUpdates

83. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin (Abstract)

Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin We compared metformin with insulin as treatment of gestational diabetes mellitus (GDM). Furthermore, we aimed to characterize metformin-treated patients needing additional insulin to achieve prespecified glucose targets.We conducted a single centre randomized controlled study with non-inferiority design comparing metformin and insulin in the treatment of 217 GDM (...) additional insulin were older (p = 0.04), their oral glucose tolerance test had been performed earlier and diabetes therapy started earlier in gestation (p = 0.01 and p = 0.004, respectively). The risk for additional insulin was 4.6-fold in women with baseline serum fructosamine concentration above median compared with those below median.Metformin is an effective alternative to insulin in the treatment of GDM patients. Serum fructosamine may help in predicting the adequacy of metformin treatment alone.©

2013 EvidenceUpdates Controlled trial quality: uncertain

84. Evaluation of the Value of Fasting Plasma Glucose in First Prenatal Visit to Diagnose Gestational Diabetes Mellitus in China Full Text available with Trip Pro

Evaluation of the Value of Fasting Plasma Glucose in First Prenatal Visit to Diagnose Gestational Diabetes Mellitus in China To evaluate the value of fasting plasma glucose (FPG) value in the first prenatal visit to diagnose gestational diabetes mellitus (GDM).Medical records of 17,186 pregnant women attending prenatal clinics in 13 hospitals in China, including the Peking University First Hospital (PUFH), were examined. Patients with pre-GDM were excluded; data for FPG at the first prenatal (...) visit and one-step GDM screening with 75-g oral glucose tolerance test (OGTT) performed between 24 and 28 weeks of gestation were collected and analyzed.The median ± SD FPG value was 4.58 ± 0.437. FPG decreased with increasing gestational age. FPG level at the first prenatal visit was strongly correlated with GDM diagnosed at 24-28 gestational weeks (χ(2) = 959.3, P < 0.001). The incidences of GDM were 37.0, 52.7, and 66.2%, respectively, for women with FPG at the first prenatal visit between 5.10

2013 EvidenceUpdates

85. Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria

Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2013 DARE.

86. Randomised controlled trial: Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)?

Randomised controlled trial: Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)? Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)? | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)? Article Text Therapeutics Randomised controlled trial Should

2013 Evidence-Based Medicine

87. Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? Full Text available with Trip Pro

Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? Werner EF (...) , Funai EF, Pettker CM, Henderson J, Zuckerwise L, Thung SF, Reel M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of criteria for the diagnosis of gestational diabetes mellitus, as proposed

2013 NHS Economic Evaluation Database.

88. Screening and diagnosing gestational diabetes mellitus

Screening and diagnosing gestational diabetes mellitus Screening and diagnosing gestational diabetes mellitus Screening and diagnosing gestational diabetes mellitus Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Aktary WM, Pasichnyk D, Seida JC, Donovan L Citation Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Aktary WM, Pasichnyk D, Seida JC, Donovan L. Screening and diagnosing gestational diabetes mellitus. Rockville: Agency for Healthcare Research and Quality (AHRQ (...) for offspring as a result of GDM and its treatment, and the "real world" effects of GDM treatment on use of care. Final publication URL Additional data URL Indexing Status Subject indexing assigned by CRD MeSH Diabetes, Gestational; Mass Screening; Pregnancy Complicationss Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence AHRQ, Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road

2012 Health Technology Assessment (HTA) Database.

89. No effect of the FitFor2 exercise programme on blood glucose, insulin sensitivity, and birthweight in pregnant women who were overweight and at risk for gestational diabetes: results of a randomised controlled trial (Abstract)

No effect of the FitFor2 exercise programme on blood glucose, insulin sensitivity, and birthweight in pregnant women who were overweight and at risk for gestational diabetes: results of a randomised controlled trial To evaluate the effectiveness of an exercise programme for pregnant women who were overweight or obese and at risk for gestational diabetes mellitus (GDM).Randomised controlled trial.Hospitals and midwifery practices in the Netherlands.Pregnant women who were overweight or obese

2012 EvidenceUpdates Controlled trial quality: uncertain

90. The usefulness of HbA1c in postpartum reclassification of gestational diabetes. (Abstract)

The usefulness of HbA1c in postpartum reclassification of gestational diabetes. To investigate the role of HbA1c in postpartum reclassification of gestational diabetes (GDM) we studied 364 women with GDM attending the postpartum reclassification assessment of their glucose tolerance status. A 75-g oral glucose tolerance test (OGTT) was performed and HbA1c was determined. Diabetes was diagnosed in 12 (3.3%), 7 (1.9%) and 2 (0.6%) women according to the fasting plasma glucose (FPG) and/or the 2 (...) -hour OGTT, the FPG alone and HbA1c levels, respectively. The sensitivity and specificity for HbA1c to diagnose diabetes was 16.7% and 100%, respectively, for FPG and OGTT criteria. The combination of a cutoff value of 5.5% for HbA1c and FPG allowed us to identify 95.1% of women with any kind of glucose intolerance. We conclude that in the early postpartum period, the cutoff of 6.5% for HbA1c alone has low sensitivity for the diagnosis of diabetes compared with OGTT, but the combination of FPG

2012 EvidenceUpdates

91. Interventions for preventing gestational diabetes mellitus: A systematic review and meta-analysis

Interventions for preventing gestational diabetes mellitus: A systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2012 DARE.

92. Treating mild gestational diabetes mellitus: a cost-effectiveness analysis Full Text available with Trip Pro

Treating mild gestational diabetes mellitus: a cost-effectiveness analysis Treating mild gestational diabetes mellitus: a cost-effectiveness analysis Treating mild gestational diabetes mellitus: a cost-effectiveness analysis Ohno MS, Sparks TN, Cheng YW, Caughey AB Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical (...) assessment on the reliability of the study and the conclusions drawn. CRD summary The objective was to assess the cost-effectiveness of treatment for mild gestational diabetes mellitus, from a societal perspective. The authors concluded that treatment for mild gestational diabetes improved both maternal and neonatal outcomes and was cost-effective. The cost-effectiveness framework was valid and the authors’ conclusions appear to be robust, but more detail on the data sources would have been useful. Type

2012 NHS Economic Evaluation Database.

93. Effects of a single post-partum injection of a high dose of vitamin D on glucose tolerance and insulin resistance in mothers with first-time gestational diabetes mellitus Full Text available with Trip Pro

Effects of a single post-partum injection of a high dose of vitamin D on glucose tolerance and insulin resistance in mothers with first-time gestational diabetes mellitus This study was performed to determine the effect of a single, large, intramuscular injection of vitamin D post-partum on glucose tolerance and insulin resistance in women with gestational diabetes.Forty-five participants in a randomized controlled trial on gestational diabetes mellitus were divided into an intervention group (...) -intervention, the median C-peptide decreased in the intervention group and increased in the control group, but the change was significant only in the control group (P = 0.03).A single injection of 300,000 IU of vitamin D3 achieves a 3-month serum 25-hydroxyvitamin D range of 50-80 nmol/l and is an efficient, effective and safe procedure for improving the vitamin status and indices of insulin resistance in mothers with gestational diabetes after delivery.© 2011 The Authors. Diabetic Medicine © 2011 Diabetes

2012 EvidenceUpdates Controlled trial quality: uncertain

94. Diabetes in Pregnancy and Gestational Diabetes Mellitus (GDM); Antidepressants in Pregnancy and Lactation

Diabetes in Pregnancy and Gestational Diabetes Mellitus (GDM); Antidepressants in Pregnancy and Lactation RxFiles Q&A Summary www.RxFiles.ca - April 2012 Lynette Kosar BSP, MSc Are Antidepressants Safe during Pregnancy & Breastfeeding? Up to ~25% of pregnant women will suffer from depression while pregnant. 1 The decision on how to treat depression and/or anxiety during & after pregnancy requires careful consideration of benefits and harms & collaborative discussions with the patient. SHOULD (...) and/or use other substances), and are less likely to take prenatal vitamins. ? There is a higher risk of spontaneous abortions, miscarriages, gestational hypertension, preeclampsia, preterm deliveries, low birth weight, small for gestational age, cesarean section, low Apgar scores, need for neonatal intensive care & ? length of hospital stay. - Some antidepressant studies have found these same risks, but most were unable to control for underlying depression. 1 ? Postpartum depression can impact

2012 RxFiles

95. Screening and Diagnosing Gestational Diabetes Mellitus

Screening and Diagnosing Gestational Diabetes Mellitus Screening and Diagnosing Gestational Diabetes Mellitus | Effective Health Care Program Search Effective Health Care website Submit search Toggle navigation Select site to search Search Effective Health Care website Submit search Screening and Diagnosing Gestational Diabetes Mellitus Nov. 5, 2012 Systematic Review Mar. 4, 2013 Disposition of Comments Report Screening and Diagnosing Gestational Diabetes Mellitus Systematic Review Archived (...) November 5, 2012 2.9 MB Related Files Archived : This report is greater than 3 years old. Findings may be used for research purposes, but should not be considered current. People using assistive technology may not be able to fully access information in these files. For additional assistance, please . Structured Abstract Background There is uncertainty as to the optimal approach for screening and diagnosis of gestational diabetes mellitus (GDM). Based on systematic reviews published in 2003 and 2008

2012 Effective Health Care Program (AHRQ)

96. Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis

Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2012 DARE.

97. Randomised controlled trial: Metformin is not significantly different from insulin for preventing fetal macrosomia in women with gestational diabetes

Randomised controlled trial: Metformin is not significantly different from insulin for preventing fetal macrosomia in women with gestational diabetes Metformin is not significantly different from insulin for preventing fetal macrosomia in women with gestational diabetes | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies (...) diabetes Article Text Therapeutics Randomised controlled trial Metformin is not significantly different from insulin for preventing fetal macrosomia in women with gestational diabetes Steve L Hyer Statistics from Altmetric.com Commentary on: Ijäs H , Vääräsmäki M , Morin-Papunen L , et al . Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. Context Evidence is accumulating that metformin is a safe alternative to insulin for the treatment

2012 Evidence-Based Medicine

98. Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis Full Text available with Trip Pro

Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis Mission JF, Ohno MS, Cheng YW, Caughey AB Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The study examined the cost-effectiveness of routine screening with the two-hour oral glucose tolerance test (OGTT) versus the one-hour glucose challenge test for gestational diabetes mellitus screening following new International Association of Diabetes in Pregnancy Study Group guidelines. The study used a valid cost-effectiveness framework and considered various

2012 NHS Economic Evaluation Database.

99. Impact of maternal diabetes mellitus on mortality and morbidity of preterm infants (24-33 weeks` gestation) (Abstract)

Impact of maternal diabetes mellitus on mortality and morbidity of preterm infants (24-33 weeks` gestation) We hypothesized that maternal diabetes mellitus (DM) increases the risk for mortality, respiratory distress syndrome (RDS), and major complications of prematurity.Analysis of prospectively collected (1995-2007) Israel National Very Low Birth Weight Infant Database. Maternal DM was recorded as pregestational or gestational. Multivariable logistic regression analysis was used to assess (...) the independent effect of maternal DM status on infant mortality, RDS, and other complications of prematurity.Infants of mothers with pregestational (n = 120) and gestational (n = 825) DM were similar, and their data were pooled for analyses. Mothers with DM were more likely to have received a complete course of prenatal steroids than control mothers. Infants of diabetic mothers (IDM) had a slightly higher gestational age and birthweight than non-IDM's. Distribution of birthweight percentiles and the mean

2011 EvidenceUpdates

100. Comparison of hemoglobin A1c with fasting plasma glucose and 2-h postchallenge glucose for risk stratification among women with recent gestational diabetes mellitus Full Text available with Trip Pro

Comparison of hemoglobin A1c with fasting plasma glucose and 2-h postchallenge glucose for risk stratification among women with recent gestational diabetes mellitus Postpartum testing with a 75-g 2-h oral glucose tolerance test or fasting plasma glucose (FPG) alone is often not performed among women with histories of gestational diabetes mellitus (GDM). Use of hemoglobin A(1c) (A1C) might increase testing. The association between A1C and glucose has not been examined in women with histories

2011 EvidenceUpdates